Literature DB >> 3349089

CD studies on the reversed heme orientation in monomeric Glycera dibranchiata hemoglobins.

R Santucci1, J Mintorovitch, I Constantinidis, J D Satterlee, F Ascoli.   

Abstract

Circular dichroism spectra of three monomeric components of Glycera dibranchiata hemoglobins are reported. Contrary to what is found for most hemoglobins and myoglobins, G. dibranchiata hemoglobins display largely negative dichroic spectra in the Soret region. Independent NMR measurements have shown that the same monomeric hemoglobin components contain the heme moiety predominantly (greater than 85%) oriented in a reversed way with respect to the orientation which occurs in most hemoglobins and myoglobins. On the basis of these independent NMR studies, and also of previous data on other invertebrate hemoproteins, a correlation appears evident between reversed heme orientation in hemoglobins and negative ellipticity in the Soret CD spectrum. This represents a simple tool to evaluate this aspect of heme asymmetric environment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3349089     DOI: 10.1016/0167-4838(88)90025-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Biosynthesis of Single Thioether c-Type Cytochromes Provides Insight into Mechanisms Intrinsic to Holocytochrome c Synthase (HCCS).

Authors:  Shalon E Babbitt; Jennifer Hsu; Deanna L Mendez; Robert G Kranz
Journal:  Biochemistry       Date:  2017-06-26       Impact factor: 3.162

2.  Haem-binding-site heterogeneity and haem Cotton effects of Glycera dibranchiata monomeric haemoglobins.

Authors:  T J DiFeo; A W Addison
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

3.  Properties of a recombinant human hemoglobin with aspartic acid 99(beta), an important intersubunit contact site, substituted by lysine.

Authors:  H Yanase; S Cahill; J J Martin de Llano; L R Manning; K Schneider; B T Chait; K D Vandegriff; R M Winslow; J M Manning
Journal:  Protein Sci       Date:  1994-08       Impact factor: 6.725

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.